tirzepatide dosage in units (Month 1) 2.5mg Health Assessment & Onboarding |

Semaglutide has a half-life of approximately 7 days, meaning the medication persists in your bloodstream long enough that a one-day delay creates only a minor gap in drug concentration

In preclinical studies, BPC-157 demonstrated an exceptionally wide therapeutic window with no observed toxicity even at high doses. Sikiric et al., Current Pharmaceutical Design Long-Term Safety As of now, long-term human safety data is lacking

Open communication with your doctor helps them tailor your dosage and manage any side effects, leading to a safer, smoother experience

Often, anxiety stems from uncertainty about whether you are doing it right

Diagnostic imaging includes compression ultrasound for suspected DVT and CT pulmonary angiography or ventilation-perfusion scanning for suspected PE, following current US clinical guidelines

Final thoughts As global obesity rates rise, GLP-1 analogues like semaglutide and tirzepatide have gained significant success, making GLP-1 and obesity indications key areas of research in drug development